DOXYCYCLINE
| Brand name | ORACEA |
|---|---|
| Active ingredient | DOXYCYCLINE |
| Strength | 40MG |
| Dosage form | CAPSULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | May 2006 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 7749532 | December 2027 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.